Merck & Company Inc (MRK)

86.100
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    86.100 - 87.300
  • Type:Equity
  • Market:Austria
  • ISIN:US58933Y1055

MRK Overview

Prev. Close
64.8
Day's Range
86.1-87.3
Revenue
-
Open
87.3
52 wk Range
58.68-87.3
EPS
-
Volume
0
Market Cap
219.58B
Dividend (Yield)
2.76
(3.08%)
Average Vol. (3m)
106
P/E Ratio
-
Beta
-
1-Year Change
38.83%
Shares Outstanding
2,528,805,025
Next Earnings Date
Jul 28, 2022
What is your sentiment on Merck&Co?
or
Vote to see community's results!

Merck & Company Inc News

Merck & Company Inc Analysis

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
67500

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong Buy
  • 🚀🚀🚀🚀🚀🚀🚀🌜
    0
    • Good, even great reasults in first quater of 2022.Let's hope to go back to 86-87 territory
      0
      • The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention.
        0
        • The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.
          0
          • The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.
            0
            • It was 22 in 1995. Do the math and look at the products.
              0
              • Hope can break 80 this week
                0
                • It should reach 120 soon
                  0
                  • Above 80 in near future. Many good things happeni.
                    0
                    • good and important rebound today.Everything above 77 will show that iwill go up later this week and month.
                      0